DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (1055)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 1055   Next >>

Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 90.7 kg (199.5 pounds)

Reactions: Fatigue, Wrist Fracture, Diarrhoea, Liver Function Test Abnormal, Anaemia, Haemorrhoids, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-07-01

VX-950
    Dosage: unk
    Administration route: Oral

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-01
    End date: 2011-10-01

Pegasys
    Dosage: 180 unk, unk
    Indication: Hepatitis C
    End date: 2012-07-01



Possible Ribavirin side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from China on 2012-08-27

Patient: male, weighing 61.5 kg (135.3 pounds)

Reactions: Occult Blood, Anaemia, Faeces Discoloured

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2009-02-01
    End date: 2009-04-07

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2008-08-01
    End date: 2009-04-07

Other drugs received by patient: Sirolimus



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-08-27

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Swelling Face, Neutropenia, Rash Pruritic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-01

Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01



Possible Ribavirin side effects in male

Reported by a physician from France on 2012-08-27

Patient: male, weighing 71.0 kg (156.2 pounds)

Reactions: Neutropenia

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C

VX-950
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C

Peginterferon Alfa-2A
    Indication: Hepatitis C

Other drugs received by patient: Dexeryl



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male

Reactions: Night Sweats, Body Temperature Increased, Anaemia, Ascites, Dysgeusia, Insomnia, Blood Uric Acid Increased, Oedema Peripheral, Sinusitis

Drug(s) suspected as cause:
Ribavirin
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-20

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-20
    End date: 2012-02-12

Pegasys
    Dosage: 180 a?g, unk
    Indication: Hepatitis C
    Start date: 2011-11-20



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male

Reactions: Drug Ineffective, Diabetes Mellitus, Urinary Tract Infection, Musculoskeletal Stiffness, Diabetic Complication, Influenza Like Illness

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-02-08
    End date: 2006-06-16

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Abscess Limb

Drug(s) suspected as cause:
Interferon
    Indication: Hepatitis C

Incivek
    Administration route: Oral
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 90.6 kg (199.3 pounds)

Reactions: Rash, Sensorimotor Disorder

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 2 df, qd
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-03-13

Ribavirin
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-29
    End date: 2012-01-18

Placebo
    Dosage: 1 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-29
    End date: 2012-01-18

GS-5885
    Dosage: 3 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-29
    End date: 2012-01-18

Investigational Drug (Unspecified)
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-29
    End date: 2012-01-18

Ribavirin
    Dosage: 600 mg, bid
    Administration route: Oral
    Start date: 2011-01-19
    End date: 2012-03-13

GS-5885
    Dosage: 3 df, qd
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-03-13

Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-19
    End date: 2012-03-09

Other drugs received by patient: Metoprolol Tartrate; Celexa; Codeine Sulfate; Sulindac; Zithromax; Tylenol; Aspirin; Ranitidine



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from Russian Federation on 2012-08-27

Patient: female

Reactions: Tooth Extraction, Oedema, Dental Care

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-16
    End date: 2012-06-29

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-16
    End date: 2012-06-29

Other drugs received by patient: Tmc435



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: , weighing 117.9 kg (259.4 pounds)

Reactions: Abscess Rupture, Peritonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-08-01

Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Start date: 2012-01-20
    End date: 2012-05-18

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-05-18

Pegasys
    Dosage: 180 a?g, unk
    Indication: Hepatitis C
    Start date: 2011-07-18
    End date: 2012-05-18



Possible Ribavirin side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-08

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-02-07

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-04

Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Monocytosis, Pyrexia, Proteinuria, Hypoalbuminaemia, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Interferon Beta NOS
    Dosage: 6 million iu, qd
    Indication: Hepatitis C
    Start date: 2011-01-26
    End date: 2011-02-09

Interferon Beta NOS
    Dosage: 6 million iu, tiw
    Start date: 2011-02-11

Ribavirin
    Dosage: 600 mg, qd 200 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-26

Other drugs received by patient: Paxil; Amoban; Teprenone; Urso 250; Lorfenamin



Possible Ribavirin side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 67 year old female

Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.94 a?g/kg, unk
    Start date: 2012-04-06
    End date: 2012-04-26

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-04-19

VX-950
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-04-13

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-08-02

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-03-30

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-22

PEG-Intron
    Dosage: 1.13 a?g/kg, unk
    Start date: 2012-04-27
    End date: 2012-05-10

VX-950
    Dosage: 2250 mg, qd
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-05-11
    End date: 2012-08-02

PEG-Intron
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-03-29

PEG-Intron
    Start date: 2012-05-11

Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine



Possible Ribavirin side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 69 year old female

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 80 unk, unk
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-21

Ribavirin
    Dosage: 400 unk, qd
    Administration route: Oral
    Start date: 2012-06-29
    End date: 2012-07-26

Ribavirin
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-03-05

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-05-04

Ribavirin
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-20

Ribavirin
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-06
    End date: 2012-06-28

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-22

Peginterferon Alfa-2B
    Dosage: 50 a?g, unk
    Start date: 2012-02-28
    End date: 2012-07-27

Other drugs received by patient: Urso / 00465701 /; Mucosta; Famotidine; Marzulene-S



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: White Blood Cell Count Decreased, Dyspnoea, Pruritus Generalised, Fatigue, Dysphonia, Depressed Mood, RED Blood Cell Count Abnormal, Cough

Drug(s) suspected as cause:
Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-01

Pegasys
    Dosage: 180 microgram, unk
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 200 mg, tid

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Pravastatin Sodium; Ambien; Prozac; Vitamin D; Trazodone HCL; Cholecalciferol; Levoxyl; Epoetin Alfa; Neupogen



Possible Ribavirin side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 54 year old female

Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-05-08

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-28

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-06-12

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-19

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-20
    End date: 2012-07-31

Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin



Possible Ribavirin side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 69 year old female

Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 80 unk, unk
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-21

Peginterferon Alfa-2B
    Dosage: 50 unk, unk
    Start date: 2012-02-28
    End date: 2012-07-27

Ribavirin
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-06
    End date: 2012-06-28

Ribavirin
    Dosage: 400 unk, qd
    Administration route: Oral
    Start date: 2012-06-29
    End date: 2012-07-26

Ribavirin
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-20

Ribavirin
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-03-05

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-22

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-05-04

Other drugs received by patient: Mucosta; Marzulene-S; Urso / 00465701 /; Famotidine



Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-24

Patient: female

Reactions: Back Pain, Oedema Peripheral, Headache

Drug(s) suspected as cause:
VX-950
    Dosage: 750 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-01
    End date: 2012-07-22

Ribavirin
    Dosage: dosage form: unspecified
    Indication: Hepatitis C
    Start date: 2012-05-01

PEG-Intron
    Dosage: dosage form: unspecified
    Indication: Hepatitis C
    Start date: 2012-05-01



Possible Ribavirin side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 61 year old male

Reactions: Retinopathy

Drug(s) suspected as cause:
VX-950
    Dosage: 1500 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-08-01

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-08-01

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2012-05-09

Ribavirin
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-06-04

Peginterferon Alfa-2B
    Dosage: 60 a?g/kg, unk
    Start date: 2012-06-21
    End date: 2012-07-26

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-08-02
    End date: 2012-08-07

Other drugs received by patient: Acetaminophen; Magmitt; Epinastine Hydrochloride; Gaster / 00661201 /; Acetaminophen



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-08-24

Patient: female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous, Pregnancy

Drug(s) suspected as cause:
Ribavirin



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Spain on 2012-08-24

Patient:

Reactions: Neutropenic Colitis, Caecitis

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatic Cirrhosis

Ribavirin
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2011-12-01

Boceprevir
    Indication: Hepatic Cirrhosis

Boceprevir
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-12-01
    End date: 2011-12-01

Peginterferon Alfa-2A
    Dosage: 180 ?g, qw
    Start date: 2011-12-01



Possible Ribavirin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Periorbital Oedema, Syncope, Anaemia, Platelet Count Decreased, Dizziness, Rash, Asthenia

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-05

Ribavirin
    Dosage: 200 mg, qd
    Start date: 2012-08-08

Ribavirin
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-05

Pegasys
    Dosage: 90 a?g/kg, unk

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05

Other drugs received by patient: Vitamin E BAR; Hydroxyzine HCL; Escitalopram; Femring MIS; Vitamin D; Progesterone; Lexapro; Ascorbic Acid



Possible Ribavirin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: male, weighing 85.5 kg (188.0 pounds)

Reactions: Pemphigus, Stevens-Johnson Syndrome

Drug(s) suspected as cause:
Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-25
    End date: 2012-07-01

Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-25
    End date: 2012-07-01

Pegasys
    Indication: Hepatitis C
    Start date: 2012-06-25
    End date: 2012-07-01

Losartan Potassium
    Dosage: 50 mg, qd
    Administration route: Oral



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Injection Site Erythema, Dyspnoea, Fatigue, Pruritus, Rash Erythematous, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-23

Patient:

Reactions: Pneumonia, Nausea, Drug Ineffective, Urine Output Decreased, Headache, Varices Oesophageal, Diarrhoea, Blood Pressure Inadequately Controlled, Upper Gastrointestinal Haemorrhage, Septic Shock, Acute Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk

Victrelis
    Dosage: unk
    Start date: 2012-02-01

Other drugs received by patient: Interferon (Unspecified)



Possible Ribavirin side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Thrombocytopenia

Drug(s) suspected as cause:
Pegasys
    Dosage: 135 microgram, qw
    Start date: 2012-05-31

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-16

Ribavirin
    Dosage: 1600 mg, qd
    Indication: Hepatitis C
    Start date: 2012-01-19

Other drugs received by patient: Oxazepam; Zolpidem Tartrate; Corgard; Folic Acid



Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: female, weighing 52.6 kg (115.8 pounds)

Reactions: White Blood Cell Count Decreased, Laboratory Test Abnormal, Malaise

Drug(s) suspected as cause:
Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-16
    End date: 2012-06-04

Incivek
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-16
    End date: 2012-06-04

Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-16
    End date: 2012-06-04



Possible Ribavirin side effects in

Reported by a physician from Spain on 2012-08-23

Patient:

Reactions: Drug Ineffective, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Intron A
    Dosage: 3 mu, tiw
    Start date: 1992-09-01
    End date: 1993-03-01

Ribavirin
    Dosage: unk
    Start date: 1999-01-01

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 1994-03-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Ribavirin
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Other drugs received by patient: Trandolapril; Verapamil; Moxonidine; Telmisartan



Possible Ribavirin side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-23

Patient: 47 year old female

Reactions: Weight Decreased, Angiotensin Converting Enzyme Increased, Subcutaneous Nodule, Aphasia, Coma, Viith Nerve Paralysis, Brain Oedema, Sarcoidosis, Acute Respiratory Failure, Lethargy, Dyspnoea, Neurological Decompensation, Lung Neoplasm, Sensation of Heaviness, Rash, Granuloma, Lymphadenopathy Mediastinal, Cerebral Sarcoidosis, Pleocytosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 ug, once a week

Ribavirin
    Dosage: 400 mg, bid
    Indication: Hepatitis C

Other drugs received by patient: Prednisolone; Prednisolone; Methylprednisolone



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014